Progression of Atrial Fibrillation in the Young

Recruiting Observational Study
Atrial Fibrillation
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Karolinska Institutet · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to investigate the presence and magnitude of structural changes of the heart and their long-term development in young patients with atrial Fibrillation (AF), studied by echocardiographic measurements and plasma biomarkers and their association to AF burden, studied using long-term ECG

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Atrial fibrillation * Diagnosis of atrial fibrillation within one year of inclusion Exclusion Criteria: * Duration of atrial fibrillation over one year. * Acute stressor for atrial fibrillation such as: acute ischemic heart disease or infection
Contacts

Piotr Sobocinski Doliwa, M.D. Ph.D.

+46812357556

piotr.sobocinski-doliwa@sll.se

CONTACT

Johan Engdahl, MD PhD

johan.engdahl@sll.se

CONTACT